DK68080A - Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod - Google Patents

Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod

Info

Publication number
DK68080A
DK68080A DK68080A DK68080A DK68080A DK 68080 A DK68080 A DK 68080A DK 68080 A DK68080 A DK 68080A DK 68080 A DK68080 A DK 68080A DK 68080 A DK68080 A DK 68080A
Authority
DK
Denmark
Prior art keywords
completely
monoglycerides
neutral fat
acetylered
cholesterine
Prior art date
Application number
DK68080A
Other languages
English (en)
Inventor
C J Gatzen
H Poethen
H Dion
Original Assignee
C J Gatzen
H Poethen
H Dion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by C J Gatzen, H Poethen, H Dion filed Critical C J Gatzen
Publication of DK68080A publication Critical patent/DK68080A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)
  • Steroid Compounds (AREA)
DK68080A 1979-02-16 1980-02-15 Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod DK68080A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2905979A DE2905979C2 (de) 1979-02-16 1979-02-16 Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen

Publications (1)

Publication Number Publication Date
DK68080A true DK68080A (da) 1980-08-17

Family

ID=6063108

Family Applications (1)

Application Number Title Priority Date Filing Date
DK68080A DK68080A (da) 1979-02-16 1980-02-15 Anvendelse af fuldstaendigt acetylerede monoglycerider til saenkning af forhoejede cholesterinspejl og eller neutralfedtspejl i menneskeblod

Country Status (5)

Country Link
US (1) US4272548A (da)
EP (1) EP0014910B1 (da)
AT (1) ATE3944T1 (da)
DE (1) DE2905979C2 (da)
DK (1) DK68080A (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056189B1 (en) * 1980-12-26 1986-08-20 Ss Pharmaceutical Co., Ltd. 2,3-butanediol diester derivatives, process for producing the same, and an antiulcer drug containing the same
US4528197A (en) * 1983-01-26 1985-07-09 Kabivitrum Ab Controlled triglyceride nutrition for hypercatabolic mammals
US4871768A (en) * 1984-07-12 1989-10-03 New England Deaconess Hospital Corporation Dietary supplement utilizing ω-3/medium chain trigylceride mixtures
SE8803141L (sv) * 1988-09-07 1990-03-08 Kabivitrum Ab Naeringsmedel foer maenniskor och djur
US5023106A (en) * 1989-03-28 1991-06-11 The Procter & Gamble Co. Process for tempering flavored confectionery compositions containing reduced calorie fats and resulting tempered products
US5662953A (en) * 1989-09-20 1997-09-02 Nabisco, Inc. Reduced calorie triglyceride mixtures
US5411756A (en) * 1989-09-20 1995-05-02 Nabisco, Inc. Reduced calorie triglyceride mixtures
US5258197A (en) * 1989-09-20 1993-11-02 Nabisco, Inc. Reduced calorie triglyceride mixtures
CA2025314A1 (en) * 1989-10-12 1991-04-13 Ronald J. Jandacek Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels
DK657689D0 (da) * 1989-12-22 1989-12-22 Novo Nordisk As Middel med biologisk virkning paa tarmslimhinden
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
EP0724389B1 (en) * 1991-03-06 2000-05-17 Nabisco, Inc. Low-palmitic, reduced-trans margarines and shortenings
JP2969234B2 (ja) * 1991-07-19 1999-11-02 株式会社アドバンス Acat阻害剤
US6129930A (en) * 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6080428A (en) * 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
IT1317885B1 (it) * 2000-08-01 2003-07-15 Sigma Tau Ind Farmaceuti Uso di fibrati per la preparazione di un medicamento utile neltrattamento dell'insufficienza cardiaca congestizia.
JP2008515407A (ja) * 2004-10-08 2008-05-15 ガムリンク エー/エス 菓子製品
US8206772B2 (en) * 2007-11-08 2012-06-26 Kraft Foods Global Brands Llc Structured lipid compositions and methods of formulation thereof
US8486478B2 (en) 2007-11-08 2013-07-16 International Great Brands LLC Structured lipid compositions
US7879384B2 (en) * 2007-11-08 2011-02-01 Kraft Foods Global Brands Llc Structured glycerol esters useful as edible moisture barriers
CA2671597A1 (en) * 2008-07-21 2010-01-21 Kraft Foods Global Brands Llc Functional no-trans oils with modulated omega-6 to omega-3 ratio
WO2010149170A1 (en) * 2009-06-24 2010-12-29 Københavns Universitet Treatment of insulin resistance and obesity by stimulating glp-1 release
US9125805B2 (en) 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN117085022A (zh) 2017-06-02 2023-11-21 Xeris药物公司 抗沉淀的小分子药物制剂

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2615159A (en) * 1949-05-28 1952-10-21 Procter & Gamble Waxy triglycerides
DE1076115B (de) * 1952-06-07 1960-02-25 Procter & Gamble Verfahren zur Herstellung einer wachsartigen, transparenten und stabilen Modifikation eines fuer Ernaehrungszwecke geeigneten Gemisches aus Diacetyltriglyceriden hoehermolekularer Fettsaeuren
FR1155903A (fr) * 1955-06-29 1958-05-09 Eastman Kodak Co Procédé pour la préparation de compositions de triglycérides mixtes, produits obtenus et leurs applications
FR1206623A (fr) * 1955-06-29 1960-02-10 Eastman Kodak Co Procédé de préparation de compositions d'esters mixtes de glycérine, produits obtenus et leurs applications
DE1767439U (de) 1958-03-14 1958-05-29 Maehler & Kaege Ag Vielpolige steckvorrichtung.
US3158541A (en) * 1959-12-18 1964-11-24 Escambia Chem Corp Product for reduction of blood cholesterol concentration
US3027259A (en) * 1960-01-05 1962-03-27 Procter & Gamble Mixed triglyceride compositions
US3203862A (en) * 1960-03-11 1965-08-31 Jones John Harris Oral anti-hypercholesterol composition
US3192057A (en) * 1961-10-06 1965-06-29 American Cyanamid Co Antibacterial coating compositions
FR3598M (fr) * 1963-03-15 1965-10-11 Drew Chem Corp Médicament pour le traitement des personnes souffrant d'une mauvaise absorption des matieres grasses.
US3388085A (en) * 1965-08-10 1968-06-11 Witco Chemical Corp Food coating compositions comprising ethylene-vinyl acetate copolymer and acetylated monoglyceride
US3495011A (en) * 1968-10-28 1970-02-10 Unimed Inc Reduction of blood level cholesterol
US3689514A (en) * 1969-05-21 1972-09-05 Schlueter Edelfett Suppository vehicle and process of making same
DE2030429C3 (de) 1970-06-20 1975-02-13 Dynamit Nobel Ag, 5210 Troisdorf Schmelzbare Überzugsmassen, insbesondere für Lebensmittel und pharmazeutische Präparate
US4034083A (en) * 1975-11-03 1977-07-05 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol

Also Published As

Publication number Publication date
DE2905979B1 (de) 1980-05-08
US4272548A (en) 1981-06-09
DE2905979C2 (de) 1981-01-22
EP0014910B1 (en) 1983-06-29
EP0014910A1 (de) 1980-09-03
ATE3944T1 (de) 1983-07-15

Similar Documents

Publication Publication Date Title
EP0014910B1 (en) Wholly acetylated monoglycerides for use for lowering of raised levels of cholesterol and/or neutral fats in human blood and process for production of pharmaceutical compositions for this purpose and dietetic foodstuffs containing them
CA1239587A (en) Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
JP3559039B2 (ja) 炎症性疾患の治療のための非経口的に投与される医薬を調製するためのエマルジョンの使用
US5178873A (en) Essential fatty acid treatment
US5116624A (en) Efa compositions and therapy
KR940018090A (ko) 트리글리세라이드
KR20040026697A (ko) 뇌기능 저하에 기인하는 증상이나 질환의 예방 또는 개선작용을 가지는 조성물
DK0515460T4 (da) Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme
ATE216227T1 (de) Phospholipide
ATE393203T1 (de) Fettzusammensetzungen
NL990032I1 (nl) Vetemulsie, werkwijze voor de bereiding daarvan ende toepassing daarvan.
EP0438483B1 (en) Triglycerides and nutritional composition comprising such triglycerides
SE7908929L (sv) Fettemulsion for intravenos injektion
ZA851046B (en) Method for directed visceral metabolism of medium chain triglycerides
AU566974B2 (en) Pharmaceutical preparations containing a phospholipidan an oxicam derivative
SE8702784D0 (sv) Komposition
DE69005298D1 (de) Arznei-lipid-zusammensetzung für parenterale nahrung.
FU MECHANISMS OF GLYCERIDE DIGESTION AND ABSORPTION: I. A STUDY OF THE DEGREE OF ACYL GROUP EXCHANGE OF TRIGLYCERIDE IN THE INTESTINAL LUMEN DURING FAT DIGESTION. II. A STUDY OF THE ABSORPTION OF 2-MONOGLYCERIDES BY WHITE RATS.
KR870009722A (ko) 지방 및 탄수화물 대사조절에서의 엔프로스틸형 프로스타글란딘의 용도
McCORRISTON Effect of an oral emulsifying agent on serum lipids in patients with chronic dermatoses
Thiam Synthesis of fish oil derived omega-3 polyunsaturated fatty acid analogs
FR2371197A1 (fr) Nouveaux derives de l'acide isobutyrique disubstitue ainsi que leur application comme medicaments
JPS604122A (ja) 抗動脈硬化性製剤

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment